FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN.
Leonteq AG (SIX: LEON), an independent expert for structured investment products and long-term savings and retirement solutions, announced today that as a result of its rights offering, a total of 2,989,593 new Leonteq registered shares have been issued and are expected to start trading on SIX Swiss Exchange tomorrow, 3 August 2018. By the end of the subscription period, 99.1% of the new registered shares offered had been validly subscribed to. Leonteq will generate net proceeds of approximately CHF 118 million from the issue of the new registered shares.
In the fully underwritten rights offering announced on 19 July 2018, a total of 2,989,593 new registered shares with a nominal value of CHF 1.00 each issued from existing authorised capital were offered to eligible Leonteq shareholders at an offer price of CHF 41.50 per share. By the end of the subscription period on 2 August 2018, 12.00 noon CEST, subscription rights for 2,963,202 new registered shares had been validly exercised, representing 99.1% of the new registered shares offered. It is planned that the 26,391 new registered shares for which subscription rights were not exercised will be sold in the market.The listing and first day of trading on SIX Swiss Exchange of the new registered shares, as well as the delivery of the new registered shares in book-entry form against payment of the offer price, are both expected to take place tomorrow, 3 August 2018.
The issued share capital of Leonteq now consists of 18,934,097 registered shares, corresponding to CHF 18,934,097. After exercising all their subscription rights in the rights offering, the stakes of Raiffeisen Switzerland (29.02%), Lukas Ruflin1 (8.15%) and Sandro Dorigo (2.45%) remain unchanged. As previously communicated, Raiffeisen Switzerland, Lukas Ruflin Family Interests, Sandro Dorigo, Leonteq and the members of Leonteq’s Board of Directors and Executive Committee have each agreed to a lock-up period of 180 days, subject to exemptions. The previous 2025 lock-up agreements for part of the shares held by Lukas Ruflin Family Interests remain in place.
Leonteq will obtain net proceeds of approximately CHF 118 million from issuing the new registered shares. It intends to use the proceeds primarily to further strengthen its capital base in order to facilitate and support the continued growth of its business. Including the net proceeds, Leonteq’s pro forma shareholders’ equity would have totalled CHF 553 million as at 30 June 2018 and its pro forma core equity tier 1 ratio would have amounted to 23.3% as at 30 June 2018, compared to 18.3% prior to the rights offering, had the capital increase taken place on that date.
1 Acting both in a personal capacity and through his family interests
DISCLAIMER NOT FOR RELEASE OR PUBLICATION IN THE UNITED STATES OF AMERICA, CANADA, JAPAN AND AUSTRALIA. This document is not an offer to sell or a solicitation of offers to purchase or subscribe for shares or any other securities. This document is not a prospectus within the meaning of Article 652a of the Swiss Code of Obligations or Article 27 et seq. of the listing rules of SIX Swiss Exchange AG or any other regulated trading venue in Switzerland or a prospectus under any other applicable laws. Copies of this document may not be sent to jurisdictions, or distributed in or sent from jurisdictions, in which this is barred or prohibited by law. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction. A decision to invest in securities of Leonteq AG should be based exclusively on the issue and listing prospectus published by Leonteq AG for such purpose. Copies of such issue and listing prospectus (and any supplements thereto) are available free of charge from Leonteq AG, Investor Relations, Europaallee 39, 8004 Zurich, Switzerland (telephone number: +41 58 800 1855; email: email@example.com).This document is not for publication or distribution in the United States of America, Canada, Australia or Japan and it does not constitute an offer or invitation to subscribe for or purchase any securities in such countries or in any other jurisdiction. In particular, the document and the information contained herein should not be distributed or otherwise transmitted into the United States of America or to publications with a general circulation in the United States of America. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the laws of any state, and may not be offered or sold in the United States of America absent registration under or an exemption from registration under the Securities Act. There will be no public offering of the securities in the United States of America. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom. This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FSMA Order") or (iii) persons falling within Articles 49(2)(a) to (d), "high net worth companies, unincorporated associations, etc." of the FSMA Order, and (iv) persons to whom an invitation or inducement to engage in investment activity within the meaning of Section 21 of the Financial Services and Markets Act 2000 may otherwise be lawfully communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any member state of the European Economic Area (each an "EEA Member State") that has implemented Directive 2003/71/EC (as amended, including by Directive 2010/73/EU, and together with any applicable implementing measures in any EEA Member State, the "Prospectus Directive") is only addressed to qualified investors in that EEA Member State within the meaning of the Prospectus Directive. This publication may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Leonteq AG and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Leonteq AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments.